公司资料
Cidara Therapeutics 股价、新闻与催化剂
- 股票代码:
- CDTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for CDTX.
公司概览
业务概览
Cidara Therapeutics is an anti-infective and immunotherapy company focused on drug-conjugate and engineered-therapy approaches. Its platform is aimed at serious infectious disease and immune-mediated conditions.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Cidara sits in specialty biotechnology.
商业模式特征
The business depends on clinical data, platform validation, and the ability to create a differentiated anti-infective franchise.
生物医药行业定位
Cidara is a catalyst-sensitive anti-infective name with meaningful dependence on program progress.
未来催化剂
- Cidara’s catalysts are CD388 and the broader antiviral/immunology platform, where the market will watch for development steps that show the lead asset can keep advancing. The company still needs clinical validation to keep the thesis strong.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。